you are here: HomeNewsAbbott india
abbott india
Jump to
104 Results Found
  • Abbott India Standalone March 2021 Net Sales at Rs 1,095.54 crore, up 13.98% Y-o-Y May 20, 2021 09:22 AM IST

    Abbott India Standalone March 2021 Net Sales at Rs 1,095.54 crore, up 13.98% Y-o-Y

  • Abbott India Q4 PAT seen up 55.7% YoY to Rs. 172.8 cr: Sharekhan Apr 12, 2021 09:02 PM IST

    Abbott India Q4 PAT seen up 55.7% YoY to Rs. 172.8 cr: Sharekhan

    Net Sales are expected to increase by 4 percent Y-o-Y (down 8.8 percent Q-o-Q) to Rs. 999.6 crore, according to Sharekhan.

  • Buy Abbott India; target of Rs 19425: Sharekhan Feb 11, 2021 03:13 PM IST

    Buy Abbott India; target of Rs 19425: Sharekhan

    Sharekhan is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 19425 in its research report dated February 09, 2021.

  • Abbott India Q3 net profit down 5% to Rs 177 crore Feb 09, 2021 06:51 PM IST

    Abbott India Q3 net profit down 5% to Rs 177 crore

    The company had posted a net profit of Rs 186.69 crore for the corresponding period of the previous fiscal, Abbott India said in a filing to BSE.

  • Abbott India Standalone December 2020 Net Sales at Rs 1,095.37 crore, up 1.59% Y-o-Y Feb 09, 2021 06:00 PM IST

    Abbott India Standalone December 2020 Net Sales at Rs 1,095.37 crore, up 1.59% Y-o-Y

  • Gladiator Stocks - Abbott India: ICICI Direct Dec 10, 2020 04:37 PM IST

    Gladiator Stocks - Abbott India: ICICI Direct

    According to ICICI Direct, Buy Abbott India in the range of Rs 15300.00–15500.00 for target price of Rs 17920.00 with a stop loss of Rs 13910.00. Time Frame: Six months.

  • Buy Abbott India: target of Rs 19,425: Sharekhan Nov 13, 2020 12:32 PM IST

    Buy Abbott India: target of Rs 19,425: Sharekhan

    Sharekhan is bullish on Abbott India recommended buy rating on the stock with a target price of Rs 19,425 in its research report dated November 11, 2020.

  • Buy Abbott India: target of Rs 19,065: ICICI Direct Nov 12, 2020 06:09 PM IST

    Buy Abbott India: target of Rs 19,065: ICICI Direct

    ICICI Direct is bullish on Abbott India recommended buy rating on the stock with a target price of Rs 19,065 in its research report dated November 11, 2020.

  • Abbott India Q2 net profit up 1% to Rs 181 crore Nov 11, 2020 05:22 PM IST

    Abbott India Q2 net profit up 1% to Rs 181 crore

    Revenue from operations remained flat at Rs 1,054.85 crore during the quarter under review as compared with Rs 1,054.80 crore in the year-ago period, Abbott India said in a regulatory filing.

  • Abbott India Standalone June 2020 Net Sales at Rs 1,064.27 crore, up 6.55% Y-o-Y Aug 10, 2020 09:33 AM IST

    Abbott India Standalone June 2020 Net Sales at Rs 1,064.27 crore, up 6.55% Y-o-Y

  • Abbott India Q1 net profit jumps 54% to Rs 180.35 crore Aug 08, 2020 01:25 PM IST

    Abbott India Q1 net profit jumps 54% to Rs 180.35 crore

    It had posted a net profit of Rs 116.94 crore for the corresponding period of the previous fiscal, Abbott India said in a late night BSE filing on Friday.

  • Buy Abbott India; target of Rs 19030: ICICI Direct Jun 15, 2020 09:43 AM IST

    Buy Abbott India; target of Rs 19030: ICICI Direct

    ICICI Direct is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 19030 in its research report dated June 09, 2020.

  • Abbott India Standalone March 2020 Net Sales at Rs 961.20 crore, up 6.06% Y-o-Y Jun 09, 2020 10:57 AM IST

    Abbott India Standalone March 2020 Net Sales at Rs 961.20 crore, up 6.06% Y-o-Y

  • Abbott India Q4 net profit declines 1.96% at Rs 110.97 crore Jun 08, 2020 08:03 PM IST

    Abbott India Q4 net profit declines 1.96% at Rs 110.97 crore

    Revenue from operations stood at Rs 961.20 crore for the quarter under consideration as against Rs 906.31 crore for the same period year ago, it added.

  • Buy Abbott India target of Rs 16880: ICICI Direct Feb 11, 2020 03:21 PM IST

    Buy Abbott India target of Rs 16880: ICICI Direct

      ICICI Direct is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 16880 in its research report dated February 10, 2020.

  • Abbott India Q3 net profit rises 59% to Rs 187cr Feb 07, 2020 07:40 PM IST

    Abbott India Q3 net profit rises 59% to Rs 187cr

    Its revenue from operations stood at Rs 1,078.25 crore for the quarter under consideration as against Rs 947.65 crore for the corresponding period a year ago.

  • FIIs reduced stake in 50 stocks that fell 50-90% in 2019; what should you do? Dec 20, 2019 09:32 AM IST

    FIIs reduced stake in 50 stocks that fell 50-90% in 2019; what should you do?

    Foreign institutional investors dumped stocks which are showing signs of a slowdown, or where there are corporate governance issues and diverted money towards blue chips.

  • Abbott India Standalone September 2019 Net Sales at Rs 1,054.80 crore, up 7.66% Y-o-Y Nov 13, 2019 10:54 AM IST

    Abbott India Standalone September 2019 Net Sales at Rs 1,054.80 crore, up 7.66% Y-o-Y

  • Abbott India Standalone September 2019 Net Sales at Rs 1,054.80 crore, up 7.66% Y-o-Y Nov 13, 2019 10:54 AM IST

    Abbott India Standalone September 2019 Net Sales at Rs 1,054.80 crore, up 7.66% Y-o-Y

  • Abbott India Q1 profit up 42% to Rs 117 crore Aug 08, 2019 06:06 PM IST

    Abbott India Q1 profit up 42% to Rs 117 crore

    Total income for the quarter under review rose to Rs 1,028.49 crore as against Rs 866.68 crore for the same period a year ago.

  • Abbott India Standalone June 2019 Net Sales at Rs 998.89 crore, up 18.22% Y-o-Y Aug 08, 2019 03:50 PM IST

    Abbott India Standalone June 2019 Net Sales at Rs 998.89 crore, up 18.22% Y-o-Y

  • Abbott India Standalone March 2019 Net Sales at Rs 906.31 crore, up 14.96% Y-o-Y May 27, 2019 04:56 PM IST

    Abbott India Standalone March 2019 Net Sales at Rs 906.31 crore, up 14.96% Y-o-Y

  • 75 BSE 500 cos can pay Rs 1.1 lakh crore more to shareholders: Report Apr 11, 2019 08:05 PM IST

    75 BSE 500 cos can pay Rs 1.1 lakh crore more to shareholders: Report

    The 75 companies can return a median of 49 percent of their total cash and cash equivalents to their shareholders.

  • Abbott India Standalone December 2018 Net Sales at Rs 947.65 crore, up 7.51% Y-o-Y Feb 11, 2019 12:03 PM IST

    Abbott India Standalone December 2018 Net Sales at Rs 947.65 crore, up 7.51% Y-o-Y

  • Abbott India Q3 net profit up marginally to Rs 117 crore Feb 08, 2019 05:00 PM IST

    Abbott India Q3 net profit up marginally to Rs 117 crore

    The company had posted a net profit of Rs 115.39 crore for the corresponding period of the previous fiscal, Abbott India said in a filing to BSE.

Sections